APO-Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Страна: Австралия

Език: английски

Източник: Department of Health (Therapeutic Goods Administration)

Активна съставка:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Предлага се от:

Arrotex Pharmaceuticals Pty Ltd

INN (Международно Name):

pemetrexed disodium hemipentahydrate

Лекарствена форма:

Injection, powder for

Композиция:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; mannitol

Начин на приложение:

Intravenous Infusion

Броя в опаковка:

1

Вид предписание :

(S4) Prescription Only Medicine

Терапевтични показания:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Каталог на резюме:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Оторизация:

Registered

Дата Оторизация:

2014-09-04